APA način citiranja

Marston, N. A., Ruff, C. T., & Sabatine, M. S. (2020). The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism. Circulation.

Čikaški stil citiranja

Marston, Nicholas A., Christian T. Ruff, i Marc S. Sabatine. "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition On the Risk of Venous Thromboembolism." Circulation 2020.

MLA način citiranja

Marston, Nicholas A., Christian T. Ruff, i Marc S. Sabatine. "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition On the Risk of Venous Thromboembolism." Circulation 2020.